Recent Posts in Drug Cases Category
Posted on Nov 5, 2009 By KBLAdmin
From ChicagoNow: A woman is suing the maker of Yaz birth control after the contraceptive allegedly caused her to develop gall stones. Melissa Johnson is suing Bayer, the maker of the prescription ...
Continue reading "Another Lawsuit Filed Against the Maker of "Yaz" Birth Control" »
Posted on Oct 19, 2009 By KBLAdmin
From BNET : Bayer faces more than 125 lawsuits over its Yaz contraceptive and new cases are being filed around the country at a rate of up to up to six a day, according to Courthouse News Service . ...
Continue reading "Bayer's Legal Woes Continue..." »
Posted on Oct 14, 2009 By KBLAdmin
Below is the beginning of a letter, written in late-2008, to the President & Chief Executive Officer of Bayer, Reinhard Franzen, from the FDA. It warns Bayer that its TV ads for Yaz are misleading ...
Continue reading "FDA to Bayer: Quit Overstating the Efficacy of Yaz and Misleading Consumers" »
Posted on Oct 8, 2009 By KBLAdmin
From The New York Times : The oral contraceptives Yaz and Yasmin are the top-selling pharmaceutical line for Bayer HealthCare , largely as a result of marketing that presents them as much more than ...
Continue reading "Bayer Misleading Consumers over Risks Associated with Popular Contraceptives" »
Posted on Aug 25, 2009 By KBLAdmin
From The Record:Will the FDA Recall Birth Control Products Yasmin & Ocella? After a birth control pill spent months in the spotlight during commercials aimed at correcting misrepresentations about ...
Continue reading "Will the FDA Recall Birth Control Products Yasmin & Ocella?" »
Posted on Aug 18, 2009 By KBLAdmin
A 22-year-old woman who was taking Ocella, a generic version of the birth control pill Yasmin , recently suffered a stroke due to taking the drug. More information on this developing case will be ...
Continue reading "Beware of Generic Birth Control Pill Ocella" »
Posted on Jun 29, 2009 By KBLAdmin
From The New York Times: WHEN it comes to corporate America, critics and skeptics are about as welcome as skunks at a pool party. And when companies try to silence dissenters, shareholders are often ...
Continue reading "Zicam" »
Posted on May 8, 2009 By KBLAdmin
From the U.S. Food and Drug Administration : Prompted by reports of serious adverse events, the U.S. Food and Drug Administration today announced that safety label changes, including a boxed warning, ...
Continue reading "FDA Slaps Botox with 'Black Box' Warning" »
Posted on May 1, 2009 By KBLAdmin
From the Los Angeles Times: by Jeannine Stein The Food and Drug Administration has issued a warning to consumers to stop using Hydroxycut dietary supplements because some have been linked to serious ...
Continue reading "FDA: Stop Using Hydroxycut Dietary Supplements Immediately" »
Posted on Nov 25, 2008 By KBLAdmin
Over the past year, Heparin , a widely used injectable anticoagulant, has come under intense scrutiny from consumer protection groups and the Food and Drug Administration. In December 2007, the FDA ...
Continue reading "FDA Warning: List of Medical Devices & Diagnostic Products that May Contain Heparin" »
Posted on Nov 19, 2008 By KBLAdmin
As President Bush does his best to rewrite federal rules aimed at pre-empting product liability litigation (50 rules that would govern product-liability laws from motorcycle brakes to pain medicine, ...
Continue reading "Wyeth v. Levine & Ethex's Morphine Sulfate: Consumers Beware!" »
Posted on Nov 18, 2008 By KBLAdmin
On Friday, November 7, 2008, the Associated Press reported that Ethex Corporation, a manufacturer of the pain medication Morphine Sulfate, is voluntarily recalling five of their generic drug brands ...
Continue reading "KV Pharmaceutical and Ethex Recall Morphine Sulfate Tablets and 17 Other Generic Products Due to Potential Life Threatening Consequences from Oversized Tablets" »
Posted on May 3, 2008 By Paul R. Kiesel
Kiesel Boucher & Larson was added on October 30, 2006, to the Executive Committee for the California Vioxx litigation. This addition allows KBL to maintain its presence on the forefront of ...
Continue reading "Vioxx Litigation" »
Posted on May 3, 2008 By Paul R. Kiesel
On September 7, 2006 Kiesel Boucher & Larson was named Lead Counsel in the Zyprexa pharmaceutical litigation pending in the Los Angeles Superior Court. Paul Kiesel is presently representing over ...
Continue reading "Zyprexa" »